First Interstate Bank’s Impax Laboratories, Inc. IPXL Stock Holding History

First Interstate Bank’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,955	Closed	-$39K	–	761
2016 Q4	$39K	Sell	2,955 -367	-11%	-$6.27K	0.01%	377
2016 Q3	$79K	Buy	+3,322	New	+$89.3K	0.02%	303
2015 Q4	–	Sell	-930	Closed	-$33K	–	830
2015 Q3	$33K	Buy	+930	New	+$41.9K	0.01%	425

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

First Interstate Bank's IPXL Position: Q1 2017 in Review

First Interstate Bank sold out of Impax Laboratories, Inc. (IPXL) in Q1 2017, closing a stake of 2,955 shares — an estimated $39K sold.

First Interstate Bank first reported a position in IPXL in Q3 2015 and held it in 3 quarters. The position peaked at $79K in Q3 2016. 178 funds tracked by Wall St. Rank hold IPXL as of Q1 2017.

First Interstate Bank reported no remaining Impax Laboratories, Inc. position as of Q1 2017 after selling out during the quarter.
First Interstate Bank sold 2,955 Impax Laboratories, Inc. shares in Q1 2017, an estimated $39K.
First Interstate Bank first reported a position in Impax Laboratories, Inc. in Q3 2015 and held it in 3 quarters.
First Interstate Bank's Impax Laboratories, Inc. position peaked at $79K in Q3 2016.
178 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2017.

Based on First Interstate Bank's 13F filing for Q1 2017, filed 11 May 2017.